The increase in cAMP and cGMP levels in the oestrogenized rat hypophysis.
Male and female rats were given oestradiol benzoate (1 mg s.c. twice a week for 3 weeks) and/or sodium nitroprusside (SN), a donor of nitric oxide (NO), which was administered in their food in amounts of 0.2 or 0.6 mg/rat/day. Neither oestradiol-induced hypertrophy of the hypophysis, nor the serum prolactin (PRL) level, was affected by the simultaneous administration of SN. The PRL content of the hypophysis rose after oestradiol in the males, but the increase was again uninfluenced by the simultaneous administration of SN and the cAMP content of the hypophysis--raised after oestradiol--was likewise unaffected. The amount of cGMP in the hypophysis after oestradiol rose only in males. Both the serum and the hypophyseal prolactin level were found to be correlated to the cAMP and the cGMP content of the hypophysis. It was found that the simultaneous administration of SN together with oestradiol slightly reduced the increase in the cGMP content of the hypophysis elicited with oestradiol treatment only.
Nedvídková
J
J
Institute of Endocrinology, First Faculty of Medicine, Charles University, Prague.
Schreiber
V
V
D000818:Animals; D000242:Cyclic AMP / Q000096:biosynthesis*; D006152:Cyclic GMP / Q000096:biosynthesis*; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006984:Hypertrophy / Q000139:chemically induced; D008297:Male; D009599:Nitroprusside / Q000494:pharmacology; D009929:Organ Size; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D011388:Prolactin / Q000097:blood; D051381:Rats; D017208:Rats, Wistar
D009599:Nitroprusside; D004958:Estradiol; D011388:Prolactin; D000242:Cyclic AMP; D006152:Cyclic GMP